SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin

Clinical trial NCT01330303 · COMPLETED

Trial details

NCT number: NCT01330303
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Hyperplasia

Start date: 2009-12-08
Primary completion: 2009-12-22
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.